The National Academy of Medicine summarizes a conversation among specialists from two universities, the Cato Institute, and the Obesity Action Coalition about the current state of GLP-1s. Here are some of the subject headings, if you’d like to read more:
Obesity Is a Complex Chronic Disease and Still Highly Stigmatized
GLP-1s Are Safe
GLP-1s Are Expensive, But Changes Are Coming
Are GLP-1s Worth the Cost? Probably
Just Increasing Access to GLP-1s Is Not Enough
The academy describes itself as offering independent and evidence-based. guidance on healthcare policy decisions. It has operated since 1970.